Our Healthcare News

EUSA Pharma and Apeiron Biologics Receive Positive CHMP Opinion for Dinutuximab Beta

HEMEL HEMPSTEAD, England and VIENNA, Austria – – EUSA Pharma (EUSA), a specialty pharmaceutical company with a focus on oncology and oncology supportive care, and…  

Mar 27 2017

Xenex Secures $38 Million in Funding Led by Essex Woodlands & Piper Jaffray Merchant Banking

SAN ANTONIO, Texas—Xenex Disinfection Services, the manufacturer of LightStrike Germ-Zapping Robots™, today announced the investment of $38 million in a funding round led by Essex…  

Feb 24 2017

Health Care Innovations are Coming to Your Digital Device

The Wall Street Journal - Opinion/Commentary

By Regina Benjamin and Adnrew Theompson

Mobile phones and tablets have pushed themselves to the center of modern life.…  

Feb 20 2017

Endologix Completes Patient Enrollment in the Ovation LUCY Study

IRVINE, California (GLOBE NEWSWIRE)—Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient enrollment in the…  

Feb 14 2017

Prolacta Bioscience Raises $35 Million in Mezzanine Financing

CITY OF INDUSTRY, California – Prolacta Bioscience®, the nation’s leading provider of human milk-based neonatal nutritional products, today announced the closing of a $35 million…  

Dec 06 2016

Metabolon Raises Additional $15 Million in Funding from Essex Woodlands

RESEARCH TRIANGLE PARK, N.C. – – Metabolon, Inc., the global leader in metabolomics, announced today that it has raised an additional $15 million in funding…  

Dec 05 2016

Metabolon Closes $15 Million Financing to Support Precision Medicine Growth Opportunities

RESEARCH TRIANGLE PARK, N.C. –– Metabolon, Inc., the global leader in metabolomics, announced today that it has closed a financing that raised $15 million from…  

Aug 11 2016

Suneva Appoints Preston Romm to Chief Executive Officer, Fortifies Board with Industry Leaders

SAN DIEGO, California —Suneva Medical, Inc., a privately‐held aesthetics company, today announced the promotion of Preston Romm to president and chief executive officer, effective immediately.…  

Aug 04 2016

Pierre Fabre Pharmaceuticals and Grupo Biotoscana enter into a Commercialization Agreement

Castres (France) and Montevideo (Uruguay) – July 25, 2016 – Pierre Fabre Pharmaceuticals, the second-largest French private pharmaceutical laboratory and Grupo Biotoscana SL (GBT), a…  

Jul 25 2016